The dairy business and industry in Oman grapples with complex challenges, from wavering milk prices and escalating input ...

Biosimilar developers should expect case-by-case evaluations, as the draft offers no hard rules on when CES will be waived. Developers are encouraged to consult the FDA early to understand evidentiary ...

LRT Capital reports +9.52% October gains, critiques AI hype, and backs undervalued picks like ABG. Discover why fundamentals ...

Strategy has become more deterministic. With customers able to discover price and value quickly and efficiently, companies ...

Businesses have been faced with how to navigate tariffs that one day may be set at 10%, only to be suddenly raised to 50% the next. Trade uncertainly is creating business uncertainty. This is an ...

The Bihar Staff Selection Commission (BSSC) is all set to conduct the BSSC Fourth Graduate Level Joint Competitive ...

As companies worldwide face geopolitical volatility—from shocks to technological disruption—there is value in revisiting ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

Carriers like Spirit and Frontier have lost customers to bigger competitors and seen their costs balloon. Some are in financial distress. By Niraj Chokshi Discount airlines reshaped the U.S. aviation ...

Executives often hash out the same words to their reports , “let us create value.” And it has become a standard language across the C-suite, value creation, and value propositions. Everyone is looking ...